These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18713521)

  • 1. Urinary buprenorphine concentrations in patients treated with suboxone as determined by liquid chromatography-mass spectrometry and CEDIA immunoassay.
    Hull MJ; Bierer MF; Griggs DA; Long WH; Nixon AL; Flood JG
    J Anal Toxicol; 2008 Sep; 32(7):516-21. PubMed ID: 18713521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.
    Marin SJ; McMillin GA
    Methods Mol Biol; 2016; 1383():69-78. PubMed ID: 26660175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine detection in urine using liquid chromatography-high-resolution mass spectrometry: comparison with cloned enzyme donor immunoassay (ThermoFisher) and homogeneous enzyme immunoassay (immunalysis).
    Belsey SL; Couchman L; Flanagan RJ
    J Anal Toxicol; 2014 Sep; 38(7):438-43. PubMed ID: 24925983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
    Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
    J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine and nor-buprenorphine levels in head hair samples from former heroin users under Suboxone® treatment.
    Belivanis S; Tzatzarakis MN; Vakonaki E; Kovatsi L; Mantsi M; Alegakis A; Kavvalakis MP; Vynias D; Tsatsakis AM
    Drug Test Anal; 2014 Jun; 6 Suppl 1():93-100. PubMed ID: 24817054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine naloxone concentration at different phases of buprenorphine maintenance treatment.
    Heikman P; Häkkinen M; Gergov M; Ojanperä I
    Drug Test Anal; 2014 Mar; 6(3):220-5. PubMed ID: 23512803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.
    Tzatzarakis MN; Vakonaki E; Kovatsi L; Belivanis S; Mantsi M; Alegakis A; Liesivuori J; Tsatsakis AM
    J Anal Toxicol; 2015 May; 39(4):313-20. PubMed ID: 25663675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of buprenorphine CEDIA assay versus GC-MS and ELISA using urine samples from patients in substitution treatment.
    Böttcher M; Beck O
    J Anal Toxicol; 2005; 29(8):769-76. PubMed ID: 16356333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tramadol use on three point-of-care and one instrument-based immunoassays for urine buprenorphine.
    Shaikh S; Hull MJ; Bishop KA; Griggs DA; Long WH; Nixon AL; Flood JG
    J Anal Toxicol; 2008 Jun; 32(5):339-43. PubMed ID: 18544218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry.
    McMillin GA; Davis R; Carlisle H; Clark C; Marin SJ; Moody DE
    J Anal Toxicol; 2012 Mar; 36(2):81-7. PubMed ID: 22337776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine is superior to oral fluid for detecting buprenorphine compliance in patients undergoing treatment for opioid addiction.
    Ransohoff JR; Petrides AK; Piscitello GJ; Flood JG; Melanson SEF
    Drug Alcohol Depend; 2019 Oct; 203():8-12. PubMed ID: 31394416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary detection times and metabolite/parent compound ratios after a single dose of buprenorphine.
    Kronstrand R; Nyström I; Andersson M; Gunnarsson L; Hägg S; Josefsson M; Ahlner J
    J Anal Toxicol; 2008 Oct; 32(8):586-93. PubMed ID: 19007507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Enzyme Immunoassay for the Detection of Buprenorphine, Norbuprenorphine and Their Glucuronides in Urine.
    Schubert B; Pitterl F; Saxl B; Pavlic M
    J Anal Toxicol; 2019 Jun; 43(5):364-368. PubMed ID: 30753557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of buprenorphine, naloxone and phase I and phase II metabolites in rat whole blood by LC-MS/MS.
    Cohier C; Salle S; Fontova A; Mégarbane B; Roussel O
    J Pharm Biomed Anal; 2020 Feb; 180():113042. PubMed ID: 31865207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved buprenorphine immunoassay performance after urine treatment with β-glucuronidase.
    Snyder ML; Darragh A; Flood JG; Jones J; Ropar K; Jarolim P; Melanson SE
    J Anal Toxicol; 2014; 38(6):375-9. PubMed ID: 24802159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Moody DE; Laycock JD; Spanbauer AC; Crouch DJ; Foltz RL; Josephs JL; Amass L; Bickel WK
    J Anal Toxicol; 1997 Oct; 21(6):406-14. PubMed ID: 9323518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hollow fiber liquid-phase microextraction combined with ultra-high performance liquid chromatography-tandem mass spectrometry for the simultaneous determination of naloxone, buprenorphine and norbuprenorphine in human plasma.
    Sun W; Qu S; Du Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 951-952():157-63. PubMed ID: 24566267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization- tandem mass spectrometry.
    Fang WB; Chang Y; McCance-Katz EF; Moody DE
    J Anal Toxicol; 2009 Oct; 33(8):409-17. PubMed ID: 19874646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Huang W; Moody DE; McCance-Katz EF
    Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of buprenorphine, naloxone and their metabolites in rat plasma using hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry.
    Joshi A; Parris B; Liu Y; Heidbreder C; Gerk PM; Halquist M
    Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27390058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.